Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Clinical Trials in TMD Sections
Author Bio
Introduction
The Biopsychosocial Model
Designing Multicenter RCTs
Players in an RCT
Randomization
Trial Design Quality
TMD Case Definition
Endpoints and Outcome Measures
Blinding & Masking
Study Sample Size
Number and Nature of Interventions
Study Length and Follow up
Intent-to-treat Analyses and Sample Size
Compliance
Multicenter RCTs
Implementing RCTs: Practical Issues
Currently selected section: Analysis of TMD Trials
Conclusions
Acknowledgments
Appendix A
Appendix B

 

Chapter 22: Clinical Trials in Temporomandibular: Analysis of TMD Trials
          

Question 17.3

Rank the following study designs listed below to evaluate therapies for TMD from highest to lowest level of evidence. Click the Answer button to see the correct sequence.

Selection AA double blind, randomized controlled trial with 1000 subjects
Selection BA double blind, controlled trial of 1000 subjects, where individuals are assigned non-randomly to each treatment group by the treating clinician
Selection CA systematic review of 10 randomized controlled trials, ranging in size from 50 to 500 subjects, using Cochrane collaboration methodology and quality assessment
Selection DA double blind, randomized controlled trial with 100 subjects

Answer Button

 

 


Page 77 of 81
      Previous Page